Antitumor activity and safety of crizotinib in patients with MET exon 14-altered advanced non-small cell lung cancer Meeting Abstract


Authors: Drilon, A.; Ou, S. H.; Clark, J.; Camidge, D. R.; Socinski, M.; Weiss, J.; Solomon, B.; Riely, G.; Heist, R.; Shapiro, G.; Wang, S.; Winter, M.; Monti, K.; Wilner, K.; Paik, P.
Abstract Title: Antitumor activity and safety of crizotinib in patients with MET exon 14-altered advanced non-small cell lung cancer
Meeting Title: IASLC 17th World Conference on Lung Cancer
Keywords: non-small cell lung cancer; met; crizotinib
Journal Title: Journal of Thoracic Oncology
Volume: 12
Issue: 1 Suppl.
Meeting Dates: 2016 Dec 4-7
Meeting Location: Vienna, Austria
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2017-01-01
Start Page: S438
End Page: S439
Language: English
ACCESSION: WOS:000413055801016
PROVIDER: wos
DOI: 10.1016/j.jtho.2016.11.512
Notes: Meeting Abstract: MA16.09 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely
  2. Paul K Paik
    255 Paik
  3. Alexander Edward Drilon
    632 Drilon